News

March 15, 2017March 15, 2017

Namilumab Therapy Successful in Phase 1b Trial of Rheumatoid Arthritis

Namilumab, an investigational monoclonal antibody that binds with high affinity to GM-CSF, shows promise in the treatment of rheumatoid arthritis (RA), new research shows. GM-CSF stands for “granulocyte macrophage colony-stimulating ... Read more

March 13, 2017March 13, 2017

Cases of RA-associated Pulmonary Hypertension Show Need for Timely Diagnosis

News, rheumatoid arthritis

A timely diagnosis and effective treatment strategy for patients with pulmonary hypertension (PH) associated with rheumatoid arthritis (RA) can prevent right heart failure and significantly enhance their quality of life, ... Read more

March 10, 2017March 10, 2017

One in Four Americans Has Arthritis, Centers for Disease Control Reports

News

One in every four Americans, or 54 million adults, has arthritis, according to a report from the Centers for Disease Control and Prevention (CDC). Twenty-four million adults must limit their activities due ... Read more

March 8, 2017March 8, 2017

Cytokine IL-21 Fuels Inflammation at Synovial Joints in RA Patients, Study Shows

News, rheumatoid arthritis

Scientists have discovered a group of immune cells that cause joint inflammation in rheumatoid arthritis (RA) by secreting a factor called interleukin (IL)-21 — a potential new target for RA therapeutics. The study ... Read more

March 6, 2017March 6, 2017

Transcript of Interview with Rheumatologist, Dr. Ara Dikranian

News, rheumatoid arthritis

Rheumatoid Arthritis News interviewed Dr. Ara Dikranian, a rheumatologist at the Cabrillo Center for Rheumatic Disease in El Cajon, California, about his experience in talking with rheumatoid arthritis (RA) patients concerning intimacy ... Read more

March 6, 2017March 6, 2017

In Interview, Rheumatologist Talks of Intimacy and Relationship Concerns of RA Patients

News

People with chronic diseases — of which rheumatoid arthritis (RA) is one — need to talk openly with their doctors about topics that might be uncomfortable, such as their relationships ... Read more

March 3, 2017March 3, 2017

Olumiant Improved RA Symptoms Better Than Humira, Study Finds

News, rheumatoid arthritis

Olumiant (baricitinib) improved patients’ outcomes in the treatment of moderate-to-severe rheumatoid arthritis (RA), in comparison to placebo and a current standard treatment, Humira (adalimumab). These findings were published in The New England ... Read more

March 1, 2017March 1, 2017

Truxima, Biosimilar of Rituximab, Approved in Europe for RA and Certain Cancers

News, rheumatoid arthritis

The European Commission approved Truxima as a biosimilar of rituximab (sold under the brand name Rituxan in the U.S.) in the EU for all indications approved for rituximab, including rheumatoid arthritis ... Read more

February 22, 2017February 22, 2017

Pfizer Reports Positive Results for Xeljanz as RA Therapy, When Combined with Methotrexate

News, rheumatoid arthritis

Pfizer recently announced top-line results from its Phase 3b/4 trial evaluating Xeljanz (tofacitinib citrate) as a treatment for moderate-to-severe rheumatoid arthritis (RA). The trial demonstrates that Xeljanz is more effective in ... Read more

February 20, 2017February 20, 2017

Vaccine Against Pneumococcal Pneumonia May Not Prevent Infection in RA Patients

News, rheumatoid arthritis

Vaccination against pneumococcal pneumonia may not protect patients with rheumatoid arthritis (RA) at risk of infection from pneumonia, according to the results of a clinical trial in Japan. The study ... Read more